ONCODESIGN PRECISION MEDICINE S.A. | WebDisclosure

Basculer en Français

9472	Companies
185370	Keywords
117723	Articles
99263	Press releases

Headlines Articles Press releases ONCODESIGN PRECISION MEDICINE S.A.

Home
Companies
ONCODESIGN PRECISION MEDICINE S.A.

PRESS RELEASE

published on 03/05/2025 at 15:52, 8 months 30 days ago

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors
Oncodesign Precision Medicine appoints Christophe Thurieau, Executive Director Research at Servier, as an independent member of the Board of Directors for a four-year term. Thurieau brings over 35 years of healthcare expertise to OPM

Board Of Directors Healthcare Christophe Thurieau Oncodesign Precision Medicine Servier
BRIEF

published on 03/05/2025 at 15:52, 8 months 30 days ago

Christophe Thurieau rejoint le Conseil d'Administration d'Oncodesign Precision Medicine

Biotechnologie Conseil D'administration Nomination Christophe Thurieau Oncodesign Precision Medicine
BRIEF

published on 03/05/2025 at 15:52, 8 months 30 days ago

Christophe Thurieau joins the Board of Directors of Oncodesign Precision Medicine

Board Of Directors Biotechnology Appointment Christophe Thurieau Oncodesign Precision Medicine
PRESS RELEASE

published on 03/05/2025 at 15:47, 8 months 30 days ago

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors
Nomination de Christophe Thurieau en tant qu’administrateur indépendant du Conseil d’Administration d’OPM. Christophe Thurieau, expert en Recherche et Développement Pharmaceutique, rejoindra OPM pour un mandat de 4 ans

Biopharmaceutique Médecine De Précision Administrateur Indépendant OPM Christophe Thurieau
BRIEF

published on 10/15/2024 at 08:05, 1 year 1 month ago

OPM-101 Phase 1 Trial Results Presented at UEG Week 2024

Ulcerative Colitis Phase 1 Trial UEG Week 2024 OPM-101 Safety Profile
BRIEF

published on 10/15/2024 at 08:05, 1 year 1 month ago

Résultats de l'essai de phase 1 OPM-101 présentés à l'UEG Week 2024

Rectocolite Hémorragique Semaine UEG 2024 OPM-101 Essai De Phase 1 Profil De Sécurité
PRESS RELEASE

published on 10/15/2024 at 08:00, 1 year 1 month ago

Inside Information / Other news releases
OPM presents safety & efficacy data on OPM-101, a novel RIPK2 kinase inhibitor, in healthy volunteers at UEG Week 2024 conference, targeting IBD treatment

Precision Medicine UEG Week 2024 OPM-101 RIPK2 Kinase Inhibitor IBD Treatment

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 36 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 41 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 11 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 6 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 11 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:01, 9 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:00, 10 minutes ago

Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 07:00, 1 hour 10 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 40 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 20 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 56 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 11 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 11 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 26 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 26 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE